Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.
The drugmaker announced a stock and warrant offering.
The FDA denied the biotech's appeal, but there's still a path forward for its drug.
TCDA earnings call for the period ending June 30, 2020.
TCDA earnings call for the period ending March 31, 2020.
TCDA earnings call for the period ending December 31, 2019.
TCDA earnings call for the period ending September 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.